These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 12482426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications.
    Kaya T, Swamy N, Persons KS, Ray S, Mohr SC, Ray R.
    Bioorg Chem; 2009 Apr; 37(2):57-63. PubMed ID: 19223058
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of the subdomain in the nuclear receptor for the hormonal form of vitamin D3, 1 alpha,25-dihydroxyvitamin D3, vitamin D receptor, that is covalently modified by an affinity labeling reagent.
    Swamy N, Kounine M, Ray R.
    Arch Biochem Biophys; 1997 Dec 01; 348(1):91-5. PubMed ID: 9390178
    [Abstract] [Full Text] [Related]

  • 6. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S, Peräkylä M, Kärkkäinen JI, Uskokovic MR, Carlberg C.
    Mol Pharmacol; 2003 Jun 01; 63(6):1230-7. PubMed ID: 12761332
    [Abstract] [Full Text] [Related]

  • 7. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM, Bishop JE, Ishizuka S, Norman AW.
    Mol Endocrinol; 2000 Nov 01; 14(11):1788-96. PubMed ID: 11075812
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C.
    J Cell Biochem; 2003 Feb 01; 88(2):274-81. PubMed ID: 12520526
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of an affinity-driven cross-linker: isolation of a vitamin D receptor associated factor.
    Swamy N, Addo JK, Ray R.
    Bioorg Med Chem Lett; 2000 Feb 21; 10(4):361-4. PubMed ID: 10714500
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the vitamin D receptor by vitamin D lactam derivatives.
    Asano L, Waku T, Abe R, Kuwabara N, Ito I, Yanagisawa J, Nagasawa K, Shimizu T.
    FEBS Lett; 2016 Sep 21; 590(18):3270-9. PubMed ID: 27500498
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
    Okano T, Nakagawa K, Tsugawa N, Ozono K, Kubodera N, Osawa A, Terada M, Mikami K.
    Biol Pharm Bull; 1998 Dec 21; 21(12):1300-5. PubMed ID: 9881643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.